X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8407) 8407
Book Review (1828) 1828
Newspaper Article (1049) 1049
Publication (506) 506
Magazine Article (115) 115
Book Chapter (90) 90
Conference Proceeding (35) 35
Trade Publication Article (27) 27
Book / eBook (23) 23
Dissertation (21) 21
Newsletter (20) 20
Web Resource (20) 20
Reference (4) 4
Paper (2) 2
Streaming Video (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6565) 6565
humans (6353) 6353
hypoglycemia (5573) 5573
diabetes (4040) 4040
female (3369) 3369
male (3351) 3351
insulin (2970) 2970
hypoglycemia - prevention & control (2929) 2929
endocrinology & metabolism (2854) 2854
glucose (2380) 2380
adult (2002) 2002
middle aged (1789) 1789
hypoglycemic agents - therapeutic use (1743) 1743
blood glucose - metabolism (1509) 1509
hypoglycemia - chemically induced (1359) 1359
aged (1352) 1352
hyperglycemia (1341) 1341
insulin - therapeutic use (1332) 1332
diabetes mellitus, type 2 - drug therapy (1313) 1313
type 2 diabetes (1274) 1274
risk factors (1256) 1256
diabetes mellitus, type 1 - drug therapy (1231) 1231
insulin - administration & dosage (1220) 1220
care and treatment (1198) 1198
hypoglycemic agents - administration & dosage (1197) 1197
blood glucose - analysis (1180) 1180
glycemic control (1147) 1147
type 1 diabetes (1147) 1147
diabetes mellitus (1145) 1145
hypoglycemic agents - adverse effects (1112) 1112
diabetes mellitus, type 1 - blood (1105) 1105
abridged index medicus (1050) 1050
research (989) 989
adolescent (977) 977
mellitus (958) 958
hyperglycemia - prevention & control (909) 909
hypoglycemia - etiology (869) 869
mortality (857) 857
diabetes therapy (851) 851
child (848) 848
diabetes mellitus, type 2 - blood (830) 830
animals (798) 798
insulin - adverse effects (772) 772
health aspects (768) 768
analysis (765) 765
treatment outcome (765) 765
management (745) 745
glycated hemoglobin a - analysis (738) 738
medicine, general & internal (727) 727
hypoglycemia - blood (717) 717
pediatrics (712) 712
patients (709) 709
prevention (699) 699
children (658) 658
blood sugar (657) 657
hypoglycemia - epidemiology (655) 655
risk (652) 652
therapy (625) 625
complications (581) 581
glycated hemoglobin a - metabolism (579) 579
dextrose (577) 577
clinical trials (575) 575
hypoglycaemia (560) 560
blood glucose - drug effects (558) 558
internal medicine (553) 553
medicine & public health (550) 550
diabetes mellitus, type 2 - complications (533) 533
diabetes mellitus, type 1 - complications (521) 521
metabolism (509) 509
studies (508) 508
time factors (494) 494
retrospective studies (488) 488
pregnancy (471) 471
infant, newborn (465) 465
diabetics (454) 454
drug therapy (454) 454
metabolic disorders (448) 448
hypoglycemia - physiopathology (443) 443
insulin infusion systems (428) 428
young adult (415) 415
exercise (412) 412
usage (412) 412
child, preschool (409) 409
blood glucose (408) 408
hypoglycemia - diagnosis (403) 403
diabetes mellitus - drug therapy (397) 397
medicine (392) 392
adults (391) 391
complications and side effects (391) 391
diagnosis (384) 384
severe hypoglycemia (382) 382
insulin resistance (381) 381
quality of life (381) 381
insulin - blood (380) 380
glycosylated hemoglobin (373) 373
follow-up studies (372) 372
rats (367) 367
association (365) 365
diabetes mellitus, type 1 - therapy (365) 365
adolescents (359) 359
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9216) 9216
German (178) 178
French (130) 130
Japanese (52) 52
Spanish (42) 42
Dutch (24) 24
Polish (20) 20
Russian (20) 20
Italian (19) 19
Chinese (10) 10
Hungarian (10) 10
Korean (10) 10
Czech (9) 9
Finnish (6) 6
Portuguese (6) 6
Danish (5) 5
Romanian (4) 4
Norwegian (3) 3
Slovak (3) 3
Swedish (3) 3
Turkish (3) 3
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 21
Background: Sodium glucose cotransporter 2 inhibitors (SGLT2i) have attracted attention by the recently reported improved cardiovascular (CV) outcomes in... 
Peptidase | Sodium | Diabetes mellitus | Body weight | Glucose | Metformin | Diabetes | Hypoglycemia | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Risk factors
Journal Article
Diabetes Technology & Therapeutics, ISSN 1520-9156, 05/2016, Volume 18, Issue 5, pp. 276 - 277
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 6/2012, Volume 32, Issue 6, pp. 1086 - 1096
Hypoglycemia-induced cerebral neuropathy can occur in patients with diabetes who attempt tight control of blood glucose and may lead to cognitive dysfunction.... 
neuron death | lactate | superoxide | hypoglycemia | microglial activation | POLY(ADP-RIBOSE) POLYMERASE | NADPH OXIDASE | DNA-DAMAGE | COGNITIVE IMPAIRMENT | NEUROSCIENCES | BRAIN LACTATE | CELL-DEATH | IN-VITRO | NAD(+) DEPLETION | ENDOCRINOLOGY & METABOLISM | HEMATOLOGY | CEREBRAL-ISCHEMIA | ENERGY SUBSTRATE | Neurons - pathology | Hypoglycemia - mortality | Male | Glycolysis - drug effects | Hypoglycemia - prevention & control | Adenosine Triphosphate - metabolism | Hypoglycemia - physiopathology | Neurons - metabolism | Cell Death - drug effects | Lactic Acid - pharmacology | Electrocardiography - methods | NAD - metabolism | Diabetic Neuropathies - physiopathology | Acute Disease | Rats | Diabetic Neuropathies - drug therapy | Hippocampus - pathology | Hypoglycemia - metabolism | Rats, Sprague-Dawley | Hippocampus - metabolism | Poly(ADP-ribose) Polymerases - metabolism | Animals | Diabetic Neuropathies - pathology | Poly (ADP-Ribose) Polymerase-1 | Diabetic Neuropathies - metabolism | Hippocampus - physiopathology | Hydrogen-Ion Concentration | Index Medicus | Neuroprotection | poly(ADP-ribose) polymerase 1 | Animal models | Diabetes mellitus | EEG | Cognitive ability | Glucose | Neuropathy | Hypoglycemia | pH effects | Blood levels | Energy resources | Energy | Sodium | Cerebral blood flow | Glycolysis | Lactic acid | Supplementation | Hippocampus | Original
Journal Article
Diabetes, ISSN 0012-1797, 11/2011, Volume 60, Issue 11, pp. 2872 - 2882
OBJECTIVE-To evaluate whether healthy or diabetic adult mice can tolerate an extreme loss of pancreatic a-cells and how this sudden massive depletion affects... 
INSULIN | HYPERGLUCAGONEMIA | ENDOCRINE PANCREAS | GLUCOSE-HOMEOSTASIS | ENDOCRINOLOGY & METABOLISM | RECEPTOR GENE | SECRETION | DIFFERENTIATION | HYPERPLASIA | ISLET CELLS | EXPRESSION | Insulin-Secreting Cells - secretion | Apoptosis - drug effects | Cell Count | Glucagon - genetics | Male | Diphtheria Toxin - toxicity | Insulin - blood | Glucagon - blood | Diabetes Mellitus, Experimental - blood | Hypoglycemia - prevention & control | Intercellular Signaling Peptides and Proteins - metabolism | Glucagon-Secreting Cells - drug effects | Insulin-Secreting Cells - metabolism | Hyperglycemia - chemically induced | Glucagon-Secreting Cells - metabolism | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - metabolism | Glucagon-Secreting Cells - secretion | Hyperglycemia - prevention & control | Promoter Regions, Genetic | Signal Transduction | Glucagon-Secreting Cells - pathology | Intercellular Signaling Peptides and Proteins - genetics | Pancreas - drug effects | Pancreas - pathology | Receptors, Glucagon - metabolism | Mice, Transgenic | Pancreas - metabolism | Heparin-binding EGF-like Growth Factor | Insulin - metabolism | Animals | Insulin-Secreting Cells - drug effects | Tamoxifen - pharmacology | Diabetes Mellitus, Experimental - pathology | Glucagon - metabolism | Mice | Streptozocin - toxicity | Insulin-Secreting Cells - pathology | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus | Abridged Index Medicus | Islet Studies
Journal Article
Diabetes obesity & metabolism, ISSN 1462-8902, 08/2017, Volume 19, Issue 8, pp. 1147 - 1154
Aims: To evaluate the effects of the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin on aortic pulse wave velocity (PWV) as a surrogate marker of arterial... 
clinical trial | cardiovascular disease | linagliptin | type 2 diabetes | DPP | antidiabetic drug | 4 inhibitor | DPP-4 inhibitor | SITAGLIPTIN | MELLITUS | PARAMETERS | ENDOTHELIAL PROGENITOR CELLS | PRESSURE | ARTERIAL STIFFNESS | GLUCOSE | INFLAMMATION | VASCULAR FUNCTION | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASES | Glycated Hemoglobin A - analysis | Follow-Up Studies | Pulse Wave Analysis | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Hypertriglyceridemia - physiopathology | Middle Aged | Linagliptin - adverse effects | Male | Linagliptin - therapeutic use | Hypoglycemia - prevention & control | Diabetic Angiopathies - physiopathology | Hypertension - prevention & control | Aorta | Female | Blood Pressure - drug effects | Diabetic Angiopathies - prevention & control | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Severity of Illness Index | Hyperglycemia - prevention & control | Double-Blind Method | Atherosclerosis - physiopathology | Atherosclerosis - complications | Biomarkers - blood | Hypertriglyceridemia - prevention & control | Diabetes Mellitus, Type 2 - blood | Hypertriglyceridemia - complications | Vascular Stiffness - drug effects | Hypertension - complications | Diabetes Mellitus, Type 2 - drug therapy | Atherosclerosis - prevention & control | Type 2 diabetes | Analysis | Atherosclerosis | Clinical trials | Glycosylated hemoglobin | Triglycerides | Hypoglycemic agents | Diabetes therapy | Blood pressure | Diabetes | Index Medicus
Journal Article
Diabetes Technology & Therapeutics, ISSN 1520-9156, 08/2019, Volume 21, Issue 8, pp. 423 - 429
Background: Reducing hyperglycemia while avoiding hypoglycemia is the key clinical goal in managing people with type 1 diabetes. Insulin delivery techniques... 
Original Articles | MDI | Insulin pump | Type 1 diabetes | ENDOCRINOLOGY & METABOLISM | INJECTIONS | MELLITUS | Hypoglycemia | CSII | Real-world evidence | Intravenous therapy | Drug delivery systems | Effectiveness | Adults | Glucose | Diabetes | Insulin | Long term | Index Medicus
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 12/2018, Volume 32, Issue 12, pp. 1091 - 1096
We investigated if a dipeptidyl peptidase-4 inhibitor, sitagliptin, can prevent perioperative stress hyperglycemia in patients without prior history of... 
Inpatient | Perioperative management | Hospital complications | DPP4-inhibitors | Stress hyperglycemia | MORTALITY | MANAGEMENT | PERIOPERATIVE GLYCEMIC CONTROL | MELLITUS | CARE | PHARMACOKINETICS | CARDIAC-SURGERY | BYPASS SURGERY | ENDOCRINOLOGY & METABOLISM | OUTCOMES | ASSOCIATION | Clinical trials | Hyperglycemia | Hypoglycemic agents | Blood sugar | Mayas | Surgery
Journal Article
2009, Document of the World Bank, ISBN 0821377582, xiii, 133
The World Bank approaches malaria not only as a major public health issue but also as a broader development problem that costs Africa US$12 billion a year and... 
prevention & control | Malaria | International Agencies | World Bank | Booster Program for Malaria Control in Africa | Africa | LEADING CAUSE OF DEATH | TETANUS | SPECIES | CONTRACTING MALARIA | GAMBIAE COMPLEX | TREATMENT | SERVICE DELIVERY | FALCIPARUM RESISTANCE | HEALTH SECTOR | MORBIDITY | HUMAN DEVELOPMENT | BURDEN OF DISEASE | ECONOMIC GROWTH | HEALTH SYSTEMS | ORAL REHYDRATION THERAPY | POTENTIAL CONTRIBUTION | PREGNANCY | PUBLIC HEALTH EXPENDITURE | HEALTH WORKERS | MALARIA ILLNESS | RESPIRATORY DISTRESS | TROPICAL DISEASES | MALARIA RATES | HEALTH SERVICES | MALARIA | ANEMIA | NATIONAL LEVEL | INSECTICIDE-TREATED NETS | MALARIA-ENDEMIC AREAS | DISASTERS | MORTALITY | PATIENTS | TUBERCULOSIS | IMPACT ON HEALTH | RISK OF MALARIA | IMPACT OF MALARIA | MALARIA INTERVENTIONS | CLIMATE CHANGE | NETS | MALARIA REPORT | DECISION MAKING | MALARIA PREVENTION | MALARIA PARASITE | NATIONAL MALARIA CONTROL | MALARIA MORBIDITY | ANOPHELES | INFORMATION SYSTEM | CONTROL OF MALARIA | HEAVY MALARIA BURDEN | HEALTH PLANNING | ANTIMALARIAL DRUGS | MEASLES IMMUNIZATION | TRANSMISSION CONTROL | ACCESS TO EFFECTIVE TREATMENT | POPULATION STRATEGY | PRIMARY EDUCATION | CEREBRAL MALARIA | HEALTH OUTCOMES | MALARIA DEATHS | PROPHYLACTIC USE | MALARIA CASES | MEDICINES | MALARIA CONTROL ACTIVITIES | AGRICULTURAL PRODUCTION | FAMILIES | DISABILITY | COMPLICATIONS | HEALTH INTERVENTIONS | MEDICAL RESEARCH | INFANT | MINISTERS OF HEALTH | MALARIA INFECTIONS | DISEASE OF POVERTY | FEBRILE ILLNESS | HEALTH SYSTEM | TREATMENT SERVICES | MOSQUITO VECTORS | HUMAN IMMUNODEFICIENCY VIRUS | HOSPITAL | HYPOGLYCEMIA | LOW BIRTHWEIGHT | QUALITY ASSURANCE | MALARIA CONTROL EFFORTS | WAR | RURAL AREAS | MEDICINE | IMMUNIZATION | MALARIA MORTALITY | MALARIA CONTROL | NATIONAL HEALTH SYSTEMS | MALARIA BURDEN | PROGRESS | BED NETS | ECONOMIC DEVELOPMENT | WORLD HEALTH ORGANIZATION | PARASITIC DISEASE | MALARIA PROGRAM | SUSTAINABLE DEVELOPMENT | IRON | HEALTH CARE | SCARCE RESOURCES | MORTALITY REDUCTION | PUBLIC HEALTH PROBLEM | MALARIA RISK | DRUG RESISTANCE | EFFECTIVE USE | NEEDS FOR INFORMATION | ECONOMIC PRODUCTIVITY | MILLENNIUM DEVELOPMENT GOAL | ANOPHELES MOSQUITO | PREVENTABLE DISEASE | REHABILITATION | INFECTION | BRAIN | CHILD SURVIVAL | INTERNATIONAL COMMUNITY | WORKERS | MALARIA DATABASE | MATERNAL MORTALITY RATIO | ORAL REHYDRATION | SEVERE ANEMIA | RESOURCE NEEDS | DISSEMINATION | PERINATAL MORTALITY | NUTRITION | RISK OF DEATH | PUBLIC HEALTH | NUMBER OF HOUSEHOLDS | MEASLES | MANDATES | TREATMENT OF MALARIA | DEVELOPMENT POLICIES | LONGEVITY | MALARIA IN PREGNANCY | ISOLATION | ANOPHELES FUNESTUS | HIGH MALARIA TRANSMISSION | GLOBAL EFFORT | BURDEN OF MALARIA | INFANT DEATHS | INTERVENTION | STILLBIRTH | HIV/AIDS | MALARIA CONTROL PROGRAMS | VULNERABLE POPULATIONS | MALARIA VECTORS | MALARIA-ENDEMIC COUNTRIES | NEGATIVE EFFECTS | DEATH RATES | MATERNAL MORTALITY | DISEASES | HIV | SULFADOXINE | PUBLIC HEALTH BURDEN | LEGAL STATUS | MILLENNIUM DEVELOPMENT GOALS | PATIENT | SOCIAL REHABILITATION | NATURAL DISASTERS | INSECTICIDES | INFECTIONS | HEALTH PROBLEMS | CAPACITY BUILDING | MALARIA INFECTION | VECTOR CONTROL PROGRAMS | ANOPHELES MOSQUITOES | MALARIA PARASITES | REPRODUCTIVE HEALTH | ANTIMALARIAL | MALARIA PROGRAMS | PREVENTIVE TREATMENT | MOSQUITO POPULATIONS | VECTORS | PARASITOLOGY | PRETERM DELIVERY | DIAGNOSIS | BRAIN DAMAGE | CLINICAL MALARIA | DISEASE CONTROL | MORBIDITY AND MORTALITY | MISCARRIAGE | POVERTY REDUCTION | VICIOUS CYCLE | GENDER EQUALITY | UNCOMPLICATED MALARIA | CHILD DEATHS | DEWORMING | IMMUNODEFICIENCY | ACQUIRED IMMUNE DEFICIENCY SYNDROME | PLASMODIUM FALCIPARUM | PYRIMETHAMINE | BACK MALARIA | INTERNATIONAL ORGANIZATIONS | CHLOROQUINE RESISTANCE | CHILD MORTALITY | SUSTAINABLE MALARIA CONTROL | TECHNICAL RESOURCES | MINISTRIES OF HEALTH | MALNUTRITION | HEALTH FACILITIES | PREGNANT WOMEN | NUMBER OF CHILDREN | HEALTH CARE SERVICES | THERAPIES | EQUITABLE ACCESS | REGIONAL NEEDS | RESIDUAL SPRAYING | MALARIOUS AREAS | POLICY MAKERS | CYCLE OF POVERTY | ADULT MOSQUITO | HEALTH SURVEYS | VECTOR CONTROL | IMMUNE DEFICIENCY | MALARIA TREATMENT
Book
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2016, Volume 31, Issue 2, pp. 479 - 482
Journal Article